Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-016-2982-1
Published Online: 2016-02-22
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goel, Varun
Hurh, Eunju
Stein, Andrew
Nedelman, Jerry
Zhou, Jocelyn
Chiparus, Ovidiu
Huang, Pai-Hsi
Gogov, Sven
Sellami, Dalila
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Text and Data Mining valid from 2016-02-22